-
1
-
-
0031004175
-
Genetic instability in colorectal cancers
-
Lengauer C., Kinzler K.W., Vogelstein B. Genetic instability in colorectal cancers. Nature 1997, 386(6625):623-627.
-
(1997)
Nature
, vol.386
, Issue.6625
, pp. 623-627
-
-
Lengauer, C.1
Kinzler, K.W.2
Vogelstein, B.3
-
2
-
-
0033831080
-
A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer
-
Khuri F.R., Nemunaitis J., Ganly I., et al. A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer. Nat Med Aug 2000, 6(8):879-885.
-
(2000)
Nat Med
, vol.6
, Issue.8
, pp. 879-885
-
-
Khuri, F.R.1
Nemunaitis, J.2
Ganly, I.3
-
3
-
-
19944363519
-
Late viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity
-
O'Shea C.C., Johnson L., Bagus B., et al. Late viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity. Cancer Cell Dec 2004, 6(6):611-623.
-
(2004)
Cancer Cell
, vol.6
, Issue.6
, pp. 611-623
-
-
O'Shea, C.C.1
Johnson, L.2
Bagus, B.3
-
4
-
-
0036645286
-
Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung
-
Sanchez-Cespedes M., Parrella P., Esteller M., et al. Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung. Cancer Res Jul 1 2002, 62(13):3659-3662.
-
(2002)
Cancer Res
, vol.62
, Issue.13
, pp. 3659-3662
-
-
Sanchez-Cespedes, M.1
Parrella, P.2
Esteller, M.3
-
5
-
-
0033522144
-
Somatic mutation of the Peutz-Jeghers syndrome gene, LKB1/STK11, in malignant melanoma
-
Guldberg P., Thor Straten P., Ahrenkiel V., Seremet T., Kirkin A.F., Zeuthen J. Somatic mutation of the Peutz-Jeghers syndrome gene, LKB1/STK11, in malignant melanoma. Oncogene Mar 4 1999, 18(9):1777-1780.
-
(1999)
Oncogene
, vol.18
, Issue.9
, pp. 1777-1780
-
-
Guldberg, P.1
Thor Straten, P.2
Ahrenkiel, V.3
Seremet, T.4
Kirkin, A.F.5
Zeuthen, J.6
-
6
-
-
77249121152
-
Homozygous deletion of the STK11/LKB1 locus and the generation of novel fusion transcripts in cervical cancer cells
-
McCabe M.T., Powell D.R., Zhou W., Vertino P.M. Homozygous deletion of the STK11/LKB1 locus and the generation of novel fusion transcripts in cervical cancer cells. Cancer Genet Cytogenet Mar 2010, 197(2):130-141.
-
(2010)
Cancer Genet Cytogenet
, vol.197
, Issue.2
, pp. 130-141
-
-
McCabe, M.T.1
Powell, D.R.2
Zhou, W.3
Vertino, P.M.4
-
7
-
-
0038614742
-
Activation of the tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRAD
-
Baas A.F., Boudeau J., Sapkota G.P., et al. Activation of the tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRAD. EMBO J Jun 16 2003, 22(12):3062-3072.
-
(2003)
EMBO J
, vol.22
, Issue.12
, pp. 3062-3072
-
-
Baas, A.F.1
Boudeau, J.2
Sapkota, G.P.3
-
8
-
-
12144287284
-
LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1
-
Lizcano J.M., Goransson O., Toth R., et al. LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO J Feb 25 2004, 23(4):833-843.
-
(2004)
EMBO J
, vol.23
, Issue.4
, pp. 833-843
-
-
Lizcano, J.M.1
Goransson, O.2
Toth, R.3
-
9
-
-
0033771625
-
In situ analysis of LKB1/STK11 mRNA expression in human normal tissues and tumours
-
Rowan A., Churchman M., Jefferey R., Hanby A., Poulsom R., Tomlinson I. In situ analysis of LKB1/STK11 mRNA expression in human normal tissues and tumours. J Pathol Oct 2000, 192(2):203-206.
-
(2000)
J Pathol
, vol.192
, Issue.2
, pp. 203-206
-
-
Rowan, A.1
Churchman, M.2
Jefferey, R.3
Hanby, A.4
Poulsom, R.5
Tomlinson, I.6
-
10
-
-
0032495530
-
A serine/threonine kinase gene defective in Peutz-Jeghers syndrome
-
Hemminki A., Markie D., Tomlinson I., et al. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature Jan 8 1998, 391(6663):184-187.
-
(1998)
Nature
, vol.391
, Issue.6663
, pp. 184-187
-
-
Hemminki, A.1
Markie, D.2
Tomlinson, I.3
-
13
-
-
80052297991
-
Frequent homozygous deletion of the LKB1/STK11 gene in non-small cell lung cancer
-
Gill R.K., Yang S.H., Meerzaman D., et al. Frequent homozygous deletion of the LKB1/STK11 gene in non-small cell lung cancer. Oncogene Sep 1 2011, 30(35):3784-3791.
-
(2011)
Oncogene
, vol.30
, Issue.35
, pp. 3784-3791
-
-
Gill, R.K.1
Yang, S.H.2
Meerzaman, D.3
-
14
-
-
84893395020
-
Integrative genomic analysis reveals a high frequency of LKB1 genetic alteration in Chinese lung adenocarcinomas
-
Fang R., Zheng C., Sun Y., et al. Integrative genomic analysis reveals a high frequency of LKB1 genetic alteration in Chinese lung adenocarcinomas. J Thorac Oncol Feb 2014, 9(2):254-258.
-
(2014)
J Thorac Oncol
, vol.9
, Issue.2
, pp. 254-258
-
-
Fang, R.1
Zheng, C.2
Sun, Y.3
-
15
-
-
33746905916
-
LKB1 mutation in large cell carcinoma of the lung
-
Zhong D., Guo L., de Aguirre I., et al. LKB1 mutation in large cell carcinoma of the lung. Lung Cancer Sep 2006, 53(3):285-294.
-
(2006)
Lung Cancer
, vol.53
, Issue.3
, pp. 285-294
-
-
Zhong, D.1
Guo, L.2
de Aguirre, I.3
-
16
-
-
34547926839
-
LKB1 modulates lung cancer differentiation and metastasis
-
Ji H., Ramsey M.R., Hayes D.N., et al. LKB1 modulates lung cancer differentiation and metastasis. Nature Aug 16 2007, 448(7155):807-810.
-
(2007)
Nature
, vol.448
, Issue.7155
, pp. 807-810
-
-
Ji, H.1
Ramsey, M.R.2
Hayes, D.N.3
-
17
-
-
84894041496
-
Transdifferentiation of lung adenocarcinoma in mice with Lkb1 deficiency to squamous cell carcinoma
-
Han X., Li F., Fang Z., et al. Transdifferentiation of lung adenocarcinoma in mice with Lkb1 deficiency to squamous cell carcinoma. Nat Commun 2014, 5:3261.
-
(2014)
Nat Commun
, vol.5
, pp. 3261
-
-
Han, X.1
Li, F.2
Fang, Z.3
-
18
-
-
0034610730
-
Epigenetic inactivation of LKB1 in primary tumors associated with the Peutz-Jeghers syndrome
-
Esteller M., Avizienyte E., Corn P.G., et al. Epigenetic inactivation of LKB1 in primary tumors associated with the Peutz-Jeghers syndrome. Oncogene Jan 6 2000, 19(1):164-168.
-
(2000)
Oncogene
, vol.19
, Issue.1
, pp. 164-168
-
-
Esteller, M.1
Avizienyte, E.2
Corn, P.G.3
-
19
-
-
0033915012
-
5'-CpG island methylation of the LKB1/STK11 promoter and allelic loss at chromosome 19p13.3 in sporadic colorectal cancer
-
Trojan J., Brieger A., Raedle J., Esteller M., Zeuzem S. 5'-CpG island methylation of the LKB1/STK11 promoter and allelic loss at chromosome 19p13.3 in sporadic colorectal cancer. Gut Aug 2000, 47(2):272-276.
-
(2000)
Gut
, vol.47
, Issue.2
, pp. 272-276
-
-
Trojan, J.1
Brieger, A.2
Raedle, J.3
Esteller, M.4
Zeuzem, S.5
-
20
-
-
1542322897
-
Methylation profiling of twenty four genes and the concordant methylation behaviours of nineteen genes that may contribute to hepatocellular carcinogenesis
-
Yu J., Zhang H.Y., Ma Z.Z., Lu W., Wang Y.F., Zhu J.D. Methylation profiling of twenty four genes and the concordant methylation behaviours of nineteen genes that may contribute to hepatocellular carcinogenesis. Cell Res Oct 2003, 13(5):319-333.
-
(2003)
Cell Res
, vol.13
, Issue.5
, pp. 319-333
-
-
Yu, J.1
Zhang, H.Y.2
Ma, Z.Z.3
Lu, W.4
Wang, Y.F.5
Zhu, J.D.6
-
21
-
-
13144290928
-
Methylation profiles of thirty four promoter-CpG islands and concordant methylation behaviours of sixteen genes that may contribute to carcinogenesis of astrocytoma
-
Yu J., Zhang H., Gu J., et al. Methylation profiles of thirty four promoter-CpG islands and concordant methylation behaviours of sixteen genes that may contribute to carcinogenesis of astrocytoma. BMC Cancer Sep 14 2004, 4:65.
-
(2004)
BMC Cancer
, vol.4
, pp. 65
-
-
Yu, J.1
Zhang, H.2
Gu, J.3
-
22
-
-
84879879429
-
Genetic and epigenetic alterations of the LKB1 gene and their associations with mutations in TP53 and EGFR pathway genes in Korean non-small cell lung cancers
-
Lee S.M., Choi J.E., Na Y.K., et al. Genetic and epigenetic alterations of the LKB1 gene and their associations with mutations in TP53 and EGFR pathway genes in Korean non-small cell lung cancers. Lung Cancer Aug 2013, 81(2):194-199.
-
(2013)
Lung Cancer
, vol.81
, Issue.2
, pp. 194-199
-
-
Lee, S.M.1
Choi, J.E.2
Na, Y.K.3
-
23
-
-
58649110598
-
Oncogenic B-RAF negatively regulates the tumor suppressor LKB1 to promote melanoma cell proliferation
-
Zheng B., Jeong J.H., Asara J.M., et al. Oncogenic B-RAF negatively regulates the tumor suppressor LKB1 to promote melanoma cell proliferation. Mol Cell Jan 30 2009, 33(2):237-247.
-
(2009)
Mol Cell
, vol.33
, Issue.2
, pp. 237-247
-
-
Zheng, B.1
Jeong, J.H.2
Asara, J.M.3
-
24
-
-
62849094740
-
Uncoupling of the LKB1-AMPKalpha energy sensor pathway by growth factors and oncogenic BRAF
-
Esteve-Puig R., Canals F., Colome N., Merlino G., Recio J.A. Uncoupling of the LKB1-AMPKalpha energy sensor pathway by growth factors and oncogenic BRAF. PLoS One 2009, 4(3):e4771.
-
(2009)
PLoS One
, vol.4
, Issue.3
, pp. e4771
-
-
Esteve-Puig, R.1
Canals, F.2
Colome, N.3
Merlino, G.4
Recio, J.A.5
-
25
-
-
0034614420
-
Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I
-
El-Mir M.Y., Nogueira V., Fontaine E., Averet N., Rigoulet M., Leverve X. Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. J Biol Chem Jan 7 2000, 275(1):223-228.
-
(2000)
J Biol Chem
, vol.275
, Issue.1
, pp. 223-228
-
-
El-Mir, M.Y.1
Nogueira, V.2
Fontaine, E.3
Averet, N.4
Rigoulet, M.5
Leverve, X.6
-
26
-
-
0034659785
-
Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain
-
Owen M.R., Doran E., Halestrap A.P. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J Jun 15 2000, 348(Pt 3):607-614.
-
(2000)
Biochem J
, vol.348
, pp. 607-614
-
-
Owen, M.R.1
Doran, E.2
Halestrap, A.P.3
-
27
-
-
84873584845
-
LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin
-
Shackelford D.B., Abt E., Gerken L., et al. LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin. Cancer Cell Feb 11 2013, 23(2):143-158.
-
(2013)
Cancer Cell
, vol.23
, Issue.2
, pp. 143-158
-
-
Shackelford, D.B.1
Abt, E.2
Gerken, L.3
-
28
-
-
78650606464
-
Beta-Subunit myristoylation is the gatekeeper for initiating metabolic stress sensing by AMP-activated protein kinase (AMPK)
-
Oakhill J.S., Chen Z.P., Scott J.W., et al. beta-Subunit myristoylation is the gatekeeper for initiating metabolic stress sensing by AMP-activated protein kinase (AMPK). Proc Natl Acad Sci U S A Nov 9 2010, 107(45):19237-19241.
-
(2010)
Proc Natl Acad Sci U S A
, vol.107
, Issue.45
, pp. 19237-19241
-
-
Oakhill, J.S.1
Chen, Z.P.2
Scott, J.W.3
-
29
-
-
34147152841
-
Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade
-
Sanders M.J., Grondin P.O., Hegarty B.D., Snowden M.A., Carling D. Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade. Biochem J Apr 1 2007, 403(1):139-148.
-
(2007)
Biochem J
, vol.403
, Issue.1
, pp. 139-148
-
-
Sanders, M.J.1
Grondin, P.O.2
Hegarty, B.D.3
Snowden, M.A.4
Carling, D.5
-
30
-
-
84892933078
-
Investigation of LKB1 Ser431 phosphorylation and Cys433 farnesylation using mouse knockin analysis reveals an unexpected role of prenylation in regulating AMPK activity
-
Houde V.P., Ritorto M.S., Gourlay R., et al. Investigation of LKB1 Ser431 phosphorylation and Cys433 farnesylation using mouse knockin analysis reveals an unexpected role of prenylation in regulating AMPK activity. Biochem. J Feb 15 2014, 458(1):41-56.
-
(2014)
Biochem. J
, vol.458
, Issue.1
, pp. 41-56
-
-
Houde, V.P.1
Ritorto, M.S.2
Gourlay, R.3
-
31
-
-
84855603512
-
Cellular and molecular mechanisms of metformin: an overview
-
Viollet B., Guigas B., Sanz Garcia N., Leclerc J., Foretz M., Andreelli F. Cellular and molecular mechanisms of metformin: an overview. Clin Sci (Lond) Mar 2012, 122(6):253-270.
-
(2012)
Clin Sci (Lond)
, vol.122
, Issue.6
, pp. 253-270
-
-
Viollet, B.1
Guigas, B.2
Sanz Garcia, N.3
Leclerc, J.4
Foretz, M.5
Andreelli, F.6
-
32
-
-
84881286031
-
Dysregulation of mTOR activity through LKB1 inactivation
-
Zhou W., Marcus A.I., Vertino P.M. Dysregulation of mTOR activity through LKB1 inactivation. Chin J Cancer Aug 2013, 32(8):427-433.
-
(2013)
Chin J Cancer
, vol.32
, Issue.8
, pp. 427-433
-
-
Zhou, W.1
Marcus, A.I.2
Vertino, P.M.3
-
33
-
-
84896995354
-
Managing lipid metabolism in proliferating cells: New perspective for metformin usage in cancer therapy
-
Lettieri Barbato D., Vegliante R., Desideri E., Ciriolo M.R. Managing lipid metabolism in proliferating cells: New perspective for metformin usage in cancer therapy. Biochim Biophys Acta Apr 2014, 1845(2):317-324.
-
(2014)
Biochim Biophys Acta
, vol.1845
, Issue.2
, pp. 317-324
-
-
Lettieri Barbato, D.1
Vegliante, R.2
Desideri, E.3
Ciriolo, M.R.4
-
34
-
-
1542618348
-
The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress
-
Shaw R.J., Kosmatka M., Bardeesy N., et al. The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc Natl Acad Sci U S A Mar 9 2004, 101(10):3329-3335.
-
(2004)
Proc Natl Acad Sci U S A
, vol.101
, Issue.10
, pp. 3329-3335
-
-
Shaw, R.J.1
Kosmatka, M.2
Bardeesy, N.3
-
35
-
-
34247881866
-
Interference with energy metabolism by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside induces HPV suppression in cervical carcinoma cells and apoptosis in the absence of LKB1
-
Nafz J., De-Castro Arce J., Fleig V., Patzelt A., Mazurek S., Rosl F. Interference with energy metabolism by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside induces HPV suppression in cervical carcinoma cells and apoptosis in the absence of LKB1. Biochem J May 1 2007, 403(3):501-510.
-
(2007)
Biochem J
, vol.403
, Issue.3
, pp. 501-510
-
-
Nafz, J.1
De-Castro Arce, J.2
Fleig, V.3
Patzelt, A.4
Mazurek, S.5
Rosl, F.6
-
36
-
-
33847009048
-
AICAR potentiates ROS production induced by chronic high glucose: roles of AMPK in pancreatic beta-cell apoptosis
-
Kim W.H., Lee J.W., Suh Y.H., et al. AICAR potentiates ROS production induced by chronic high glucose: roles of AMPK in pancreatic beta-cell apoptosis. Cell Signal Apr 2007, 19(4):791-805.
-
(2007)
Cell Signal
, vol.19
, Issue.4
, pp. 791-805
-
-
Kim, W.H.1
Lee, J.W.2
Suh, Y.H.3
-
37
-
-
34247898927
-
Involvement of AMPK signaling cascade in capsaicin-induced apoptosis of HT-29 colon cancer cells
-
Kim Y.M., Hwang J.T., Kwak D.W., Lee Y.K., Park O.J. Involvement of AMPK signaling cascade in capsaicin-induced apoptosis of HT-29 colon cancer cells. Ann N Y Acad Sci Jan 2007, 1095:496-503.
-
(2007)
Ann N Y Acad Sci
, vol.1095
, pp. 496-503
-
-
Kim, Y.M.1
Hwang, J.T.2
Kwak, D.W.3
Lee, Y.K.4
Park, O.J.5
-
38
-
-
0345107247
-
Complexes between the LKB1 tumor suppressor, STRADalpha/beta and MO25alpha/beta are upstream kinases in the AMP-activated protein kinase cascade
-
Hawley S.A., Boudeau J., Reid J.L., et al. Complexes between the LKB1 tumor suppressor, STRADalpha/beta and MO25alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J Biol 2003, 2(4):28.
-
(2003)
J Biol
, vol.2
, Issue.4
, pp. 28
-
-
Hawley, S.A.1
Boudeau, J.2
Reid, J.L.3
-
39
-
-
0035857020
-
New drug targets for type 2 diabetes and the metabolic syndrome
-
Moller D.E. New drug targets for type 2 diabetes and the metabolic syndrome. Nature Dec 13 2001, 414(6865):821-827.
-
(2001)
Nature
, vol.414
, Issue.6865
, pp. 821-827
-
-
Moller, D.E.1
-
40
-
-
85047689953
-
5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells?
-
Corton J.M., Gillespie J.G., Hawley S.A., Hardie D.G. 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells?. Eur J Biochem Apr 15 1995, 229(2):558-565.
-
(1995)
Eur J Biochem
, vol.229
, Issue.2
, pp. 558-565
-
-
Corton, J.M.1
Gillespie, J.G.2
Hawley, S.A.3
Hardie, D.G.4
-
41
-
-
34547870106
-
Pharmacological activators of AMP-activated protein kinase have different effects on Na+ transport processes across human lung epithelial cells
-
Woollhead A.M., Sivagnanasundaram J., Kalsi K.K., et al. Pharmacological activators of AMP-activated protein kinase have different effects on Na+ transport processes across human lung epithelial cells. Br J Pharmacol Aug 2007, 151(8):1204-1215.
-
(2007)
Br J Pharmacol
, vol.151
, Issue.8
, pp. 1204-1215
-
-
Woollhead, A.M.1
Sivagnanasundaram, J.2
Kalsi, K.K.3
-
42
-
-
0041802820
-
Targeting mTOR signaling for cancer therapy
-
Huang S., Houghton P.J. Targeting mTOR signaling for cancer therapy. Curr Opin Pharmacol Aug 2003, 3(4):371-377.
-
(2003)
Curr Opin Pharmacol
, vol.3
, Issue.4
, pp. 371-377
-
-
Huang, S.1
Houghton, P.J.2
-
43
-
-
70349378469
-
Enhancing mTOR-targeted cancer therapy
-
Wang X., Sun S.Y. Enhancing mTOR-targeted cancer therapy. Expert Opin Ther Targets Oct 2009, 13(10):1193-1203.
-
(2009)
Expert Opin Ther Targets
, vol.13
, Issue.10
, pp. 1193-1203
-
-
Wang, X.1
Sun, S.Y.2
-
44
-
-
84892743258
-
A genetic mouse model of invasive endometrial cancer driven by concurrent loss of Pten and Lkb1 Is highly responsive to mTOR inhibition
-
Cheng H., Liu P., Zhang F., et al. A genetic mouse model of invasive endometrial cancer driven by concurrent loss of Pten and Lkb1 Is highly responsive to mTOR inhibition. Cancer Res Jan 1 2014, 74(1):15-23.
-
(2014)
Cancer Res
, vol.74
, Issue.1
, pp. 15-23
-
-
Cheng, H.1
Liu, P.2
Zhang, F.3
-
45
-
-
84900393562
-
Loss of Lkb1 and Pten Leads to Lung Squamous Cell Carcinoma with Elevated PD-L1 Expression
-
Xu C., Fillmore C.M., Koyama S., et al. Loss of Lkb1 and Pten Leads to Lung Squamous Cell Carcinoma with Elevated PD-L1 Expression. Cancer Cell Apr 30 2014.
-
(2014)
Cancer Cell
-
-
Xu, C.1
Fillmore, C.M.2
Koyama, S.3
-
46
-
-
84875234347
-
Dysregulation of RNA polymerase I transcription during disease
-
Hannan K.M., Sanij E., Rothblum L.I., Hannan R.D., Pearson R.B. Dysregulation of RNA polymerase I transcription during disease. Biochim Biophys Acta 2013, 1829(3-4):342-360.
-
(2013)
Biochim Biophys Acta
, vol.1829
, Issue.3-4
, pp. 342-360
-
-
Hannan, K.M.1
Sanij, E.2
Rothblum, L.I.3
Hannan, R.D.4
Pearson, R.B.5
-
47
-
-
84863736613
-
Inhibition of RNA polymerase I as a therapeutic strategy to promote cancer-specific activation of p53
-
Bywater M.J., Poortinga G., Sanij E., et al. Inhibition of RNA polymerase I as a therapeutic strategy to promote cancer-specific activation of p53. Cancer Cell 2012, 22(1):51-65.
-
(2012)
Cancer Cell
, vol.22
, Issue.1
, pp. 51-65
-
-
Bywater, M.J.1
Poortinga, G.2
Sanij, E.3
-
48
-
-
0037291736
-
ERK-dependent phosphorylation of the transcription initiation factor TIF-IA is required for RNA polymerase I transcription and cell growth
-
Zhao J., Yuan X., Frodin M., Grummt I. ERK-dependent phosphorylation of the transcription initiation factor TIF-IA is required for RNA polymerase I transcription and cell growth. Mol Cell Feb 2003, 11(2):405-413.
-
(2003)
Mol Cell
, vol.11
, Issue.2
, pp. 405-413
-
-
Zhao, J.1
Yuan, X.2
Frodin, M.3
Grummt, I.4
-
49
-
-
1542343973
-
MTOR-dependent activation of the transcription factor TIF-IA links rRNA synthesis to nutrient availability
-
Mayer C., Zhao J., Yuan X., Grummt I. mTOR-dependent activation of the transcription factor TIF-IA links rRNA synthesis to nutrient availability. Genes Dev Feb 15 2004, 18(4):423-434.
-
(2004)
Genes Dev
, vol.18
, Issue.4
, pp. 423-434
-
-
Mayer, C.1
Zhao, J.2
Yuan, X.3
Grummt, I.4
-
50
-
-
70449584566
-
AMP-activated protein kinase adapts rRNA synthesis to cellular energy supply
-
Hoppe S., Bierhoff H., Cado I., et al. AMP-activated protein kinase adapts rRNA synthesis to cellular energy supply. Proc Natl Acad Sci U S A Oct 20 2009, 106(42):17781-17786.
-
(2009)
Proc Natl Acad Sci U S A
, vol.106
, Issue.42
, pp. 17781-17786
-
-
Hoppe, S.1
Bierhoff, H.2
Cado, I.3
-
51
-
-
78650465738
-
LKB1 regulated pathways in lung cancer invasion and metastasis
-
Marcus A.I., Zhou W. LKB1 regulated pathways in lung cancer invasion and metastasis. J Thorac Oncol Dec 2010, 5(12):1883-1886.
-
(2010)
J Thorac Oncol
, vol.5
, Issue.12
, pp. 1883-1886
-
-
Marcus, A.I.1
Zhou, W.2
-
52
-
-
77953238558
-
Integrative genomic and proteomic analyses identify targets for Lkb1-deficient metastatic lung tumors
-
Carretero J., Shimamura T., Rikova K., et al. Integrative genomic and proteomic analyses identify targets for Lkb1-deficient metastatic lung tumors. Cancer Cell Jun 15 2010, 17(6):547-559.
-
(2010)
Cancer Cell
, vol.17
, Issue.6
, pp. 547-559
-
-
Carretero, J.1
Shimamura, T.2
Rikova, K.3
-
53
-
-
84879050733
-
LKB1 represses focal adhesion kinase (FAK) signaling via a FAK-LKB1 complex to regulate FAK site maturation and directional persistence
-
Kline E.R., Shupe J., Gilbert M.M., Zhou W., Marcus A.I. LKB1 represses focal adhesion kinase (FAK) signaling via a FAK-LKB1 complex to regulate FAK site maturation and directional persistence. J Biol Chem May 1 2013.
-
(2013)
J Biol Chem
-
-
Kline, E.R.1
Shupe, J.2
Gilbert, M.M.3
Zhou, W.4
Marcus, A.I.5
-
54
-
-
84881508779
-
Metabolic and functional genomic studies identify deoxythymidylate kinase as a target in LKB1-mutant lung cancer
-
Liu Y., Marks K., Cowley G.S., et al. Metabolic and functional genomic studies identify deoxythymidylate kinase as a target in LKB1-mutant lung cancer. Cancer Discov Aug 2013, 3(8):870-879.
-
(2013)
Cancer Discov
, vol.3
, Issue.8
, pp. 870-879
-
-
Liu, Y.1
Marks, K.2
Cowley, G.S.3
-
55
-
-
80052977483
-
Localization-specific LKB1 loss in head and neck squamous cell carcinoma metastasis
-
Kline E.R., Muller S., Pan L., Tighiouart M., Chen Z.G., Marcus A.I. Localization-specific LKB1 loss in head and neck squamous cell carcinoma metastasis. Head Neck Oct 2011, 33(10):1501-1512.
-
(2011)
Head Neck
, vol.33
, Issue.10
, pp. 1501-1512
-
-
Kline, E.R.1
Muller, S.2
Pan, L.3
Tighiouart, M.4
Chen, Z.G.5
Marcus, A.I.6
-
56
-
-
84904038159
-
LKB1 when associated with methylatedERa is a marker of bad prognosis in breast cancer
-
Bouchekioua-Bouzaghou K., Poulard C., Rambaud J., et al. LKB1 when associated with methylatedERa is a marker of bad prognosis in breast cancer. Int J Cancer Feb 12 2014.
-
(2014)
Int J Cancer
-
-
Bouchekioua-Bouzaghou, K.1
Poulard, C.2
Rambaud, J.3
-
57
-
-
44949122687
-
STRADalpha regulates LKB1 localization by blocking access to importin-alpha, and by association with Crm1 and exportin-7
-
Dorfman J., Macara I.G. STRADalpha regulates LKB1 localization by blocking access to importin-alpha, and by association with Crm1 and exportin-7. Mol Biol Cell Apr 2008, 19(4):1614-1626.
-
(2008)
Mol Biol Cell
, vol.19
, Issue.4
, pp. 1614-1626
-
-
Dorfman, J.1
Macara, I.G.2
-
58
-
-
84894531752
-
AMP-activated protein kinase (AMPK) beyond metabolism: a novel genomic stress sensor participating in the DNA damage response pathway
-
Sanli T., Steinberg G.R., Singh G., Tsakiridis T. AMP-activated protein kinase (AMPK) beyond metabolism: a novel genomic stress sensor participating in the DNA damage response pathway. Cancer Biol Ther Feb 2014, 15(2):156-169.
-
(2014)
Cancer Biol Ther
, vol.15
, Issue.2
, pp. 156-169
-
-
Sanli, T.1
Steinberg, G.R.2
Singh, G.3
Tsakiridis, T.4
-
59
-
-
77955917717
-
Ionizing radiation activates AMP-activated kinase (AMPK): a target for radiosensitization of human cancer cells
-
Sanli T., Rashid A., Liu C., et al. Ionizing radiation activates AMP-activated kinase (AMPK): a target for radiosensitization of human cancer cells. Int J Radiat Oncol Biol Phys Sep 1 2010, 78(1):221-229.
-
(2010)
Int J Radiat Oncol Biol Phys
, vol.78
, Issue.1
, pp. 221-229
-
-
Sanli, T.1
Rashid, A.2
Liu, C.3
-
60
-
-
84867045698
-
A role of DNA-dependent protein kinase for the activation of AMP-activated protein kinase in response to glucose deprivation
-
Amatya P.N., Kim H.B., Park S.J., et al. A role of DNA-dependent protein kinase for the activation of AMP-activated protein kinase in response to glucose deprivation. Biochim Biophys Acta Dec 2012, 1823(12):2099-2108.
-
(2012)
Biochim Biophys Acta
, vol.1823
, Issue.12
, pp. 2099-2108
-
-
Amatya, P.N.1
Kim, H.B.2
Park, S.J.3
-
61
-
-
17644362355
-
DNA damage-induced association of ATM with its target proteins requires a protein interaction domain in the N terminus of ATM
-
Fernandes N., Sun Y., Chen S., et al. DNA damage-induced association of ATM with its target proteins requires a protein interaction domain in the N terminus of ATM. J Biol Chem Apr 15 2005, 280(15):15158-15164.
-
(2005)
J Biol Chem
, vol.280
, Issue.15
, pp. 15158-15164
-
-
Fernandes, N.1
Sun, Y.2
Chen, S.3
-
62
-
-
0036901639
-
Ionizing radiation induces ataxia telangiectasia mutated kinase (ATM)-mediated phosphorylation of LKB1/STK11 at Thr-366
-
Sapkota G.P., Deak M., Kieloch A., et al. Ionizing radiation induces ataxia telangiectasia mutated kinase (ATM)-mediated phosphorylation of LKB1/STK11 at Thr-366. Biochem J Dec 1 2002, 368(Pt 2):507-516.
-
(2002)
Biochem J
, vol.368
, pp. 507-516
-
-
Sapkota, G.P.1
Deak, M.2
Kieloch, A.3
-
63
-
-
77749233738
-
ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS
-
Alexander A., Cai S.L., Kim J., et al. ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS. Proc Natl Acad Sci U S A Mar 2 2010, 107(9):4153-4158.
-
(2010)
Proc Natl Acad Sci U S A
, vol.107
, Issue.9
, pp. 4153-4158
-
-
Alexander, A.1
Cai, S.L.2
Kim, J.3
-
64
-
-
77956994837
-
Differential localization of ATM is correlated with activation of distinct downstream signaling pathways
-
Alexander A., Walker C.L. Differential localization of ATM is correlated with activation of distinct downstream signaling pathways. Cell Cycle Sep 15 2010, 9(18):3685-3686.
-
(2010)
Cell Cycle
, vol.9
, Issue.18
, pp. 3685-3686
-
-
Alexander, A.1
Walker, C.L.2
-
65
-
-
84887383501
-
Repair of oxidative DNA damage and cancer: recent progress in DNA base excision repair
-
Scott T.L., Rangaswamy S., Wicker C.A., Izumi T. Repair of oxidative DNA damage and cancer: recent progress in DNA base excision repair. Antioxid Redox Signal Feb 1 2014, 20(4):708-726.
-
(2014)
Antioxid Redox Signal
, vol.20
, Issue.4
, pp. 708-726
-
-
Scott, T.L.1
Rangaswamy, S.2
Wicker, C.A.3
Izumi, T.4
-
66
-
-
84886787846
-
Systematic identification of molecular subtype-selective vulnerabilities in non-small-cell lung cancer
-
Kim H.S., Mendiratta S., Kim J., et al. Systematic identification of molecular subtype-selective vulnerabilities in non-small-cell lung cancer. Cell Oct 24 2013, 155(3):552-566.
-
(2013)
Cell
, vol.155
, Issue.3
, pp. 552-566
-
-
Kim, H.S.1
Mendiratta, S.2
Kim, J.3
-
68
-
-
84891748709
-
The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment
-
Johnson R., Halder G. The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment. Nat Rev Drug Discov Jan 2014, 13(1):63-79.
-
(2014)
Nat Rev Drug Discov
, vol.13
, Issue.1
, pp. 63-79
-
-
Johnson, R.1
Halder, G.2
-
69
-
-
84902513006
-
In melanoma, Hippo signaling is affected by copy number alterations and YAP1 overexpression impairs patient survival
-
Menzel M., Meckbach D., Weide B., et al. In melanoma, Hippo signaling is affected by copy number alterations and YAP1 overexpression impairs patient survival. Pigment Cell Melanoma Res Apr 4 2014.
-
(2014)
Pigment Cell Melanoma Res
-
-
Menzel, M.1
Meckbach, D.2
Weide, B.3
-
70
-
-
53849087493
-
Expression of Yes-associated protein in common solid tumors
-
Steinhardt A.A., Gayyed M.F., Klein A.P., et al. Expression of Yes-associated protein in common solid tumors. Hum Pathol Nov 2008, 39(11):1582-1589.
-
(2008)
Hum Pathol
, vol.39
, Issue.11
, pp. 1582-1589
-
-
Steinhardt, A.A.1
Gayyed, M.F.2
Klein, A.P.3
-
71
-
-
77953197857
-
Overexpression of yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer
-
Wang Y., Dong Q., Zhang Q., Li Z., Wang E., Qiu X. Overexpression of yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer. Cancer science May 2010, 101(5):1279-1285.
-
(2010)
Cancer science
, vol.101
, Issue.5
, pp. 1279-1285
-
-
Wang, Y.1
Dong, Q.2
Zhang, Q.3
Li, Z.4
Wang, E.5
Qiu, X.6
-
72
-
-
84883488932
-
LKB1 tumor suppressor regulates AMP kinase/mTOR-independent cell growth and proliferation via the phosphorylation of Yap
-
Nguyen H.B., Babcock J.T., Wells C.D., Quilliam L.A. LKB1 tumor suppressor regulates AMP kinase/mTOR-independent cell growth and proliferation via the phosphorylation of Yap. Oncogene Aug 29 2013, 32(35):4100-4109.
-
(2013)
Oncogene
, vol.32
, Issue.35
, pp. 4100-4109
-
-
Nguyen, H.B.1
Babcock, J.T.2
Wells, C.D.3
Quilliam, L.A.4
-
73
-
-
84891345748
-
A genetic screen identifies an LKB1-MARK signalling axis controlling the Hippo-YAP pathway
-
Mohseni M., Sun J., Lau A., et al. A genetic screen identifies an LKB1-MARK signalling axis controlling the Hippo-YAP pathway. Nat Cell Biol Jan 2014, 16(1):108-117.
-
(2014)
Nat Cell Biol
, vol.16
, Issue.1
, pp. 108-117
-
-
Mohseni, M.1
Sun, J.2
Lau, A.3
-
74
-
-
84862605178
-
Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP
-
Liu-Chittenden Y., Huang B., Shim J.S., et al. Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP. Genes Dev Jun 15 2012, 26(12):1300-1305.
-
(2012)
Genes Dev
, vol.26
, Issue.12
, pp. 1300-1305
-
-
Liu-Chittenden, Y.1
Huang, B.2
Shim, J.S.3
-
75
-
-
84896092147
-
A peptide mimicking VGLL4 function acts as a YAP antagonist therapy against gastric cancer
-
Jiao S., Wang H., Shi Z., et al. A peptide mimicking VGLL4 function acts as a YAP antagonist therapy against gastric cancer. Cancer Cell Feb 10 2014, 25(2):166-180.
-
(2014)
Cancer Cell
, vol.25
, Issue.2
, pp. 166-180
-
-
Jiao, S.1
Wang, H.2
Shi, Z.3
-
76
-
-
84876563391
-
Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
-
Yang W., Soares J., Greninger P., et al. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res Jan 2013, 41(Database issue):D955-961.
-
(2013)
Nucleic Acids Res
, vol.41
, Issue.DATABASE ISSUE
, pp. D955-961
-
-
Yang, W.1
Soares, J.2
Greninger, P.3
-
77
-
-
0346057795
-
Stability of the Peutz-Jeghers syndrome kinase LKB1 requires its binding to the molecular chaperones Hsp90/Cdc37
-
Nony P., Gaude H., Rossel M., Fournier L., Rouault J.P., Billaud M. Stability of the Peutz-Jeghers syndrome kinase LKB1 requires its binding to the molecular chaperones Hsp90/Cdc37. Oncogene Dec 11 2003, 22(57):9165-9175.
-
(2003)
Oncogene
, vol.22
, Issue.57
, pp. 9165-9175
-
-
Nony, P.1
Gaude, H.2
Rossel, M.3
Fournier, L.4
Rouault, J.P.5
Billaud, M.6
-
78
-
-
0037444766
-
Heat-shock protein 90 and Cdc37 interact with LKB1 and regulate its stability
-
Boudeau J., Deak M., Lawlor M.A., Morrice N.A., Alessi D.R. Heat-shock protein 90 and Cdc37 interact with LKB1 and regulate its stability. Biochem J Mar 15 2003, 370(Pt 3):849-857.
-
(2003)
Biochem J
, vol.370
, pp. 849-857
-
-
Boudeau, J.1
Deak, M.2
Lawlor, M.A.3
Morrice, N.A.4
Alessi, D.R.5
-
79
-
-
84865213364
-
The double edge of the HSP90-CDC37 chaperone machinery: opposing determinants of kinase stability and activity
-
Xu W., Neckers L. The double edge of the HSP90-CDC37 chaperone machinery: opposing determinants of kinase stability and activity. Future Oncol Aug 2012, 8(8):939-942.
-
(2012)
Future Oncol
, vol.8
, Issue.8
, pp. 939-942
-
-
Xu, W.1
Neckers, L.2
-
80
-
-
84860407614
-
Molecular chaperone complexes with antagonizing activities regulate stability and activity of the tumor suppressor LKB1
-
Gaude H., Aznar N., Delay A., et al. Molecular chaperone complexes with antagonizing activities regulate stability and activity of the tumor suppressor LKB1. Oncogene Mar 22 2012, 31(12):1582-1591.
-
(2012)
Oncogene
, vol.31
, Issue.12
, pp. 1582-1591
-
-
Gaude, H.1
Aznar, N.2
Delay, A.3
-
81
-
-
84896521425
-
Loss of LKB1 expression reduces the latency of ErbB2-mediated mammary gland tumorigenesis, promoting changes in metabolic pathways
-
Andrade-Vieira R., Xu Z., Colp P., Marignani P.A. Loss of LKB1 expression reduces the latency of ErbB2-mediated mammary gland tumorigenesis, promoting changes in metabolic pathways. PLoS One. 2013, 8(2):e56567.
-
(2013)
PLoS One.
, vol.8
, Issue.2
, pp. e56567
-
-
Andrade-Vieira, R.1
Xu, Z.2
Colp, P.3
Marignani, P.A.4
-
82
-
-
78650488264
-
LKB1 inhibits lung cancer progression through lysyl oxidase and extracellular matrix remodeling
-
Gao Y., Xiao Q., Ma H., et al. LKB1 inhibits lung cancer progression through lysyl oxidase and extracellular matrix remodeling. Proc Natl Acad Sci U S A Nov 2 2010, 107(44):18892-18897.
-
(2010)
Proc Natl Acad Sci U S A
, vol.107
, Issue.44
, pp. 18892-18897
-
-
Gao, Y.1
Xiao, Q.2
Ma, H.3
-
83
-
-
84896031764
-
Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors
-
Sausville E., Lorusso P., Carducci M., et al. Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors. Cancer Chemother Pharmacol Mar 2014, 73(3):539-549.
-
(2014)
Cancer Chemother Pharmacol
, vol.73
, Issue.3
, pp. 539-549
-
-
Sausville, E.1
Lorusso, P.2
Carducci, M.3
-
84
-
-
84883487392
-
Phase I, dose-escalation study of AZD7762 alone and in combination with gemcitabine in Japanese patients with advanced solid tumours
-
Seto T., Esaki T., Hirai F., et al. Phase I, dose-escalation study of AZD7762 alone and in combination with gemcitabine in Japanese patients with advanced solid tumours. Cancer Chemother Pharmacol Sep 2013, 72(3):619-627.
-
(2013)
Cancer Chemother Pharmacol
, vol.72
, Issue.3
, pp. 619-627
-
-
Seto, T.1
Esaki, T.2
Hirai, F.3
|